Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Open-Label Study of INCB018424 Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer

NCT00638378 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT00638378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00638378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Open-Label Study of INCB018424 Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer
Lead sponsor
Incyte Corporation
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2008
Completion date
January 31, 2009
Enrollment
22 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer